Reviewing Quorum Health Corporation (QHC) & Its Competitors

Quorum Health Corporation (NYSE: QHC) is one of 17 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its competitors? We will compare Quorum Health Corporation to related companies based on the strength of its risk, institutional ownership, dividends, valuation, profitability, analyst recommendations and earnings.

Profitability

This table compares Quorum Health Corporation and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quorum Health Corporation -8.28% -38.34% -3.34%
Quorum Health Corporation Competitors 5.01% 6.11% 5.07%

Analyst Ratings

This is a summary of recent ratings for Quorum Health Corporation and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quorum Health Corporation 1 3 0 0 1.75
Quorum Health Corporation Competitors 57 320 500 9 2.52

Quorum Health Corporation currently has a consensus target price of $3.88, indicating a potential downside of 20.76%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 11.39%. Given Quorum Health Corporation’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Quorum Health Corporation has less favorable growth aspects than its competitors.

Institutional & Insider Ownership

82.0% of Quorum Health Corporation shares are owned by institutional investors. Comparatively, 64.7% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 4.7% of Quorum Health Corporation shares are owned by company insiders. Comparatively, 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Quorum Health Corporation has a beta of 8.72, indicating that its share price is 772% more volatile than the S&P 500. Comparatively, Quorum Health Corporation’s competitors have a beta of 1.49, indicating that their average share price is 49% more volatile than the S&P 500.

Valuation & Earnings

This table compares Quorum Health Corporation and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Quorum Health Corporation $2.42 billion -$347.68 million -0.78
Quorum Health Corporation Competitors $1.06 billion -$22.56 million 526.60

Quorum Health Corporation has higher revenue, but lower earnings than its competitors. Quorum Health Corporation is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Quorum Health Corporation competitors beat Quorum Health Corporation on 9 of the 12 factors compared.

Quorum Health Corporation Company Profile

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery and rehabilitation services.

Receive News & Ratings for Quorum Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply